Showing results (611-620 of 816) with videos related to
Sort By:
Pageof 82
Experimental Hematology|May 1, 1995
Effects of rhIL-11 on normal dogs and after sublethal radiationR A Nash, K Seidel, R Storb, et al.Transplantation|November 1, 1987
Facilitation of engraftment of DLA-nonidentical marrow by treatment of recipients with monoclonal antibody directed against marrow cells surviving radiationF Schuening, R Storb, S Goehle, et al.Blood|October 1, 1976
Allogeneic marrow grafting for treatment of aplastic anemia: a follow-up on long-term survivorsR Storb, E D Thomas, C D Buckner, et al.Transplantation|November 1, 1992
Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetoneR F Raff, R Storb, T Graham, et al.Blood|September 1, 1995
A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemiaP Kalhs, I Schwarzinger, G Anderson, et al.Experimental Hematology|November 1, 1984
Pulmonary function of marrow transplant patients. I. Effects of marrow infusion, acute graft-versus-host disease, and interstitial pneumonitisS C Springmeyer, R C Silvestri, N Flournoy, et al.Blood|October 1, 1992
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexateR A Nash, M S Pepe, R Storb, et al.Bone Marrow Transplantation|October 20, 2009
CD3(+) and/or CD14(+) depletion from cord blood mononuclear cells before ex vivo expansion culture improves total nucleated cell and CD34(+) cell yieldsH Yang, S N Robinson, J Lu, et al.Bone Marrow Transplantation|July 27, 2004
Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease responseP Anderlini, S A Acholonu, G-J Okoroji, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2001
Impact of high-dose chemotherapy on peripheral T-cell lymphomasJ Rodriguez, M Munsell, S Yazji, et al.Pageof 82